One of the more mechanically interesting clearances on the FDA's June 4, 2026 list is K253102: the GT Metabolic MagDI System, comprising components MAG-01, MAG-02, and DS-01, from Gt Metabolic Solutions, Inc. The product code is SAH, the regulation is 21 CFR 878.4816, the advisory committee is General and Plastic Surgery, the class is II, and the clearance is a Traditional 510(k) found Substantially Equivalent. The FDA's generic name for the SAH code is the giveaway: “Magnetic Compression Anastomosis System.” This is a device that joins two hollow organs together using magnets, and the regulatory category exists specifically for that technique.
To appreciate why this is novel, start with what an anastomosis is and how surgeons normally make one. An anastomosis is a surgically created connection between two structures — most commonly two cut ends or two walls of bowel, so that intestinal contents can pass through a new opening. The conventional ways to make one are sutures, hand-sewn loop by loop, or surgical staplers that fire rows of titanium staples and cut an opening between them. Both work, and both have the same fundamental property: they leave foreign material — suture or staples — permanently at the join, and the connection's integrity depends on those mechanical fasteners holding through the early healing period, when an anastomotic leak is the feared complication.
How magnetic compression anastomosis actually works
Magnetic compression anastomosis takes a different physical route to the same biological result. The MagDI system uses two magnetic components — the MAG-01 and MAG-02 in the cleared system — that are placed on either side of the two tissue walls to be joined, one in each lumen. The magnets attract each other across the intervening tissue and clamp the two walls together with a sustained, controlled compressive force. That is the whole mechanism, and the elegance is in what happens next. The tissue caught between the two magnets is under constant pressure; it loses its blood supply and undergoes pressure necrosis, while at the same time the tissue immediately around the rim of the magnets — where pressure is lower — heals and fuses the two walls together. Over days, the central compressed tissue dies and sloughs, leaving a clean, fused opening between the two lumens exactly where the magnets sat. The now-joined magnet pair, having created the opening it was clamping, is freed into the lumen and passes out of the body naturally through the GI tract. The DS-01 is the delivery component that positions the magnets.
The clinical pitch follows directly from the mechanism. There is no permanent implant: the magnets leave the body. The anastomosis is formed by the body's own healing around a gradually applied, even compression, rather than held by point-loaded staples or sutures. And because the technique can be deployed without the open or stapler-based manipulation a conventional anastomosis requires, it opens the door to less invasive ways of creating bowel connections. The “DI” in MagDI and the company's metabolic-surgery focus point toward applications in bariatric and metabolic procedures, where creating a controlled connection between segments of the GI tract is the operative goal — though the precise cleared indication is defined in the 510(k) summary, and a careful reader should anchor the specific intended use to that document rather than to the device name.
The substantial-equivalence logic
The existence of a dedicated product code — SAH, Magnetic Compression Anastomosis System, under 878.4816 — is itself the key to the clearance pathway. As with other purpose-built classifications, this code almost certainly traces back to a De Novo classification that established magnetic compression anastomosis as a recognized device type with its own special controls. Once that classification exists, a new magnetic-anastomosis system can clear through a Traditional 510(k) by demonstrating substantial equivalence to a predicate device of the same type, rather than having to argue equivalence to a fundamentally different technology like a surgical stapler.
That predicate choice is what makes the substantial-equivalence case coherent. Trying to argue that a magnet system is equivalent to a stapler would invite exactly the problem 510(k) is designed to flag — different technological characteristics that raise new questions of safety and effectiveness. The mechanism of tissue joining is entirely different, the failure modes are different, and the foreign-body profile is different. By instead citing a prior magnetic compression anastomosis device as predicate, the sponsor compares like with like: same intended use of creating an anastomosis, same fundamental technology of paired-magnet compression and pressure necrosis. The remaining analysis narrows to the specifics — magnet geometry, the compressive force profile, the delivery system, the materials — and whether the differences from the predicate alter the safety or effectiveness of the join.
The evidentiary spine for a device in this class is the demonstration that the anastomosis it creates is sound: that it forms reliably, achieves adequate patency, and does not leak at a rate worse than the accepted standard. The special controls for the 878.4816 classification drive at exactly those questions — biocompatibility of the magnet materials, the mechanical characterization of the compressive force, animal and clinical evidence of reliable anastomosis formation, and labeling that bounds the indicated use. For a 510(k) following an established predicate, the burden is to show the new system performs equivalently along those axes.
Why the technique is worth watching
Magnetic compression anastomosis is one of those device categories where the physics is old — the idea of using magnets to join tissue dates back decades — but the engineering to make it reliable and deliverable is recent. The hard problems are controlling the compressive force so that it is high enough to cause clean necrosis at the center but graded enough to let the rim heal, ensuring the magnet pair reliably frees itself and passes, and delivering the magnets to the right place without open surgery. Each cleared device in the SAH code is a data point in how well those problems have been solved in a shippable product.
For GT Metabolic, a Class II clearance for the MagDI system is the regulatory foundation for bringing a sutureless, stapleless, implant-free anastomosis technique into U.S. practice. The substance to read in the cleared summary is the bench and clinical characterization of the anastomosis: the force profile, the patency and leak data, and the precise population and procedure the device is indicated for. The classification establishes that magnetic compression anastomosis is a recognized device type; the summary establishes how well this particular implementation creates the join its mechanism promises.